Actelion Shares Surge on Drug Test Result

Shares in Actelion surged nearly 15% after the Swiss biotechnology giant said an experimental heart-and-lung drug met targets in a late-stage study.



from WSJ.com: US Business http://ift.tt/1qjK8XG

via IFTTT